Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury.
Saved in:
| Title: | Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury. |
|---|---|
| Authors: | Kim EB; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA., Malespini JE; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA., Lei M; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA., Han SS; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA., Minsky CW; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA., Branagan AR; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., O'Donnell EK; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Cirstea D; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Raje NS; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA., Yee AJ; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA. |
| Source: | Blood advances [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3129-3135. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
